About: Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic
Creator	Moschese, Viviana Cardinale, Fabio Marseglia, Gian Ciprandi, Giorgio Galli, Elena Novembre, Elio Peroni, Diego Tripodi, Salvatore Tosca, Maria Barberi, Salvatore Bernardini, Roberto Caffarelli, Carlo Calvani, Mauro Cavagni, Giovanni Minasi, Domenico Paravati, Francesco Traina, Giovanni Miraglia Del Giudice, Michele
Source	Medline; PMC
abstract	The COVID-19 pandemic has surprised the entire population. The world has had to face an unprecedented pandemic. Only, Spanish flu had similar disastrous consequences. As a result, drastic measures (lockdown) have been adopted worldwide. Healthcare service has been overwhelmed by the extraordinary influx of patients, often requiring high intensity of care. Mortality has been associated with severe comorbidities, including chronic diseases. Patients with frailty were, therefore, the victim of the SARS-COV-2 infection. Allergy and asthma are the most prevalent chronic disorders in children and adolescents, so they need careful attention and, if necessary, an adaptation of their regular treatment plans. Fortunately, at present, young people are less suffering from COVID-19, both as incidence and severity. However, any age, including infancy, could be affected by the pandemic. Based on this background, the Italian Society of Pediatric Allergy and Immunology has felt it necessary to provide a Consensus Statement. This expert panel consensus document offers a rationale to help guide decision-making in the management of children and adolescents with allergic or immunologic diseases.
has issue date	2020-06-16(xsd:dateTime)
bibo:doi	10.1186/s13052-020-00843-2
bibo:pmid	32546234
has license	cc-by
sha1sum (hex)	1943a11703bae397c6e77dc4a1e196b505f92275
schema:url	https://doi.org/10.1186/s13052-020-00843-2
resource representing a document's title	Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic
has PubMed Central identifier	PMC7296524
has PubMed identifier	32546234
schema:publication	Ital J Pediatr
resource representing a document's body	covid:1943a11703bae397c6e77dc4a1e196b505f92275#body_text
is schema:about of	named entity 'high' named entity 'Society' named entity 'pandemic' named entity 'MORTALITY' named entity 'COULD BE' named entity 'MANAGEMENT' named entity 'immunologic' named entity 'prevalent' named entity 'Patients' named entity 'result' named entity 'lockdown' named entity 'decision-making' named entity 'asthma' named entity 'COVID' named entity 'lockdown' named entity 'decision-making' named entity 'asthma' named entity 'drastic measures' named entity 'surprised' named entity 'Immunoglobulin' named entity 'higher risk' named entity 'allergens' named entity 'azithromycin' named entity 'latex' named entity 'eczema' named entity 'disinfectant' named entity 'immunization' named entity 'infection' named entity 'influenza vaccination' named entity 'milk' named entity 'hypoallergenic' named entity 'allergic' named entity 'weight loss' named entity 'immunodeficiencies' named entity 'hypersensitivity' named entity 'spina bifida' named entity 'cyclosporine' named entity 'immunosuppressive' named entity 'hygiene' named entity 'chemotherapeutic agents' named entity 'treatment of patients' named entity 'OFC' named entity 'plasma or serum' named entity 'immune response' named entity 'Allergy' named entity 'antibiotics' named entity 'viruses' named entity 'infection' named entity 'COVID' named entity 'H1-antihistamines' named entity 'elimination diet' named entity 'latex' named entity 'American Academy of Pediatrics' named entity 'immunotherapy' named entity 'adverse effects' named entity 'allergy' named entity 'asthma medications' named entity 'immunization' named entity 'eosinophilic esophagitis' named entity 'allergic' named entity 'allergic' named entity 'rhinitis' named entity 'PPE' named entity 'infection'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software